Hoya, Eclipse in aesthetic laser pact:
This article was originally published in Clinica
Executive Summary
Dental and aesthetic medical laser specialist Hoya ConBio has signed an exclusive three-year distribution agreement with Eclipse Medical for its MedLite C series and RevLite lasers. Eclipse will distribute the lasers in Texas, Louisiana, Arkansas and Oklahoma. Hoya (Freemont, California) claims that the MedLite C series and RevLite lasers, which use Q-switched Nd:YAG laser engineering, represent the next generation of laser engineering. This is because they treat patients via the delivery of energy with a "PhotoAcoustic" effect, as opposed to photothermal energy, which other devices use. These lasers are already used widely for tattoo removal, but also have potential uses for wrinkle reduction, acne scars, vascular and pigmented lesions and hair removal.
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.